Achievement of goals in U.S. diabetes care, 1999-2010

New England Journal of Medicine

Volumn 368, Issue 17, 2013, Pages 1613-1624

  Ali, Mohammed K ^a,b   Bullard, Kai McKeever ^a   Saaddine, Jinan B ^a   Cowie, Catherine C ^c   Imperatore, Giuseppina ^a   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; EYE EXAMINATION; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MOUTH EXAMINATION; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SMOKING HABIT; TREND STUDY; UNITED STATES;

EID: 84876550739     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1213829     Document Type: Article

References (40)

1. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: Centers for Disease Control and Prevention, 2011.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
3. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-53. [Erratum, Lancet 1999;354:602.]
4. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
5. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53. (Pubitemid 41817713)
6. Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-25.
7. The UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
8. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007;131:446-52. (Pubitemid 46280405)
9. Standards of medical care in diabetes - 2012. Diabetes Care 2012;35:Suppl 1:S11-S63.
10. Ahmann AJ. Guidelines and performance measures for diabetes. Am J Manag Care 2007;13:Suppl 2:S41-S46. (Pubitemid 46656061)
11. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. JAMA 2011;305:709-10.
12. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74. (Pubitemid 46780669)
13. The TRIAD Study Group. Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD Study. Diabetes Care 2010;33:940-7.
14. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91. (Pubitemid 351214285)
15. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39. [Errata, N Engl J Med 2009;361:1024-5, 1028.]
16. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
17. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
18. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79.
19. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 2011;154:554-9.
20. National Health and Nutrition Examination Survey: questionnaires, datasets, and related documentation. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm).
21. Behavioral Risk Factor Surveillance System: survey data and documentation. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/brfss/technical-infodata/surveydata.htm).
22. Performance measures - endocrine: diabetes. Washington, DC: National Quality Forum, 2013 (http://www.qualityforum.org/QPS).
23. Laiteerapong N, John PM, Nathan AG, Huang ES. Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabetes Care 2013;36:84-9.
24. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-9. [Erratum, Clin Sci (Lond) 2002;102:679.] (Pubitemid 33135349)
25. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
26. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6. (Pubitemid 20255621)
27. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009;6(4):e1000058.
28. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98. (Pubitemid 46883773)
29. O'Connor PJ, Bodkin NL, Fradkin J, et al. Diabetes performance measures: current status and future directions. Diabetes Care 2011;34:1651-9. [Erratum, Diabetes Care 2011;34:2631.]
30. Kralewski JE, Dowd BE, Xu YW. Medical groups can reduce costs by investing in improved quality of care for patients with diabetes. Health Aff (Millwood) 2012;31:1830-5.
31. Rossi MC, Lucisano G, Comaschi M, et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care 2011;34:347-52.
32. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006. Diabetes Care 2012;35:1252-7.
33. Diabetes data and trends: hospitalization. Atlanta: Centers for Disease Control and Prevention, 2012 (http://www.cdc.gov/diabetes/statistics/ hospitalization-national.htm).
34. Riddle MC, Ambrosius WT, Brillon DJ, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010;33:983-90.
35. Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-94.
36. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999;22:403-8. (Pubitemid 29106894)
37. Gary TL, Narayan KM, Gregg EW, Beckles GL, Saaddine JB. Racial/ethnic differences in the healthcare experience (coverage, utilization, and satisfaction) of US adults with diabetes. Ethn Dis 2003;13:47-54. (Pubitemid 36443069)
38. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Health of previously uninsured adults after acquiring Medicare coverage. JAMA 2007;298:2886-94.
39. National Committee for Quality Assurance. The state of health care quality. October 2012 (http://www.ncqa.org/Portals/0/State%20of%20Health%20Care/ 2012/SOHC%20Report%20Web.pdf).
40. Ratner RE. Diabetes management in the age of national health reform. Diabetes Care 2011;34:1054-7.